[Congressional Record Volume 164, Number 50 (Thursday, March 22, 2018)]
[Senate]
[Pages S1981-S1982]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
Unanimous Consent Request--H.R. 5247
Mr. JOHNSON. Mr. President, I realize the hour is late. I will move
quickly to my unanimous consent request, but I want to quickly state
that this is so important that this can't wait, and I am really asking
a pretty simple request of my colleagues that we stop playing games
with people's lives because it is well past time that we passed the
Right to Try. The Trickett Wendler, Frank Mongiello, Jordan McLinn, and
Matthew Bellina Right to Try Act of 2018.
We passed this unanimously through the Senate in August. The House
has acted now. I am just asking my colleagues, please, these desperate
patients are terminally ill, and they have waited far too long.
Mr. President, I ask unanimous consent that the Senate proceed to the
immediate consideration of H.R. 5247, which was received from the
House. I ask unanimous consent that the bill be considered read a third
time and passed and the motion to reconsider be considered made and
laid upon the table.
The PRESIDING OFFICER. Is there objection?
The Democratic leader.
Mr. SCHUMER. Mr. President, reserving the right to object, and I will
object.
I just want to make clear that I am sympathetic to the goals my
friends from Wisconsin and Indiana are trying to accomplish. In fact,
the Senate has already passed a version of this bill once and dedicated
time to work on the outstanding issues to get a good compromise and
pass it into law and pass it into law quickly.
I believe we all support the goals of safety and increasing access of
investigational drugs for terminally ill people, but the key is we need
to ensure there are safety mechanisms in place when we do this. A
significant part of that is making sure the FDA is part of the process.
They already have an expanded access program. We need to ensure that we
are not increasing the risk of patient harm or endangering clinical
trials so lifesaving drugs can continue to be developed and people have
access to them.
So I assure my colleagues that we will work together to get something
done, and done quickly, because this is an important issue. People who
have terminal illnesses deserve every opportunity and chance at
survival, and I look forward to working with my colleagues and moving
forward on the Senate bill.
With that, Mr. President, I object.
The PRESIDING OFFICER. Objection is heard.
The Senator from Wisconsin.
Mr. JOHNSON. Mr. President, I do want to point out the fact that the
Right to Try bill only allows access to drugs that have already passed
phase 1 safety approval from the FDA. There has been an awful lot of
misunderstanding from that standpoint.
All we are asking is, what this bill would do is allow terminal
patients who have no other options--they have exhausted all treatment
options, they do not qualify for a clinical trial, they are near death
or, according to the House bill, subject to severely premature death.
It just gives those individuals the right to choose for themselves, not
have a faceless bureaucrat at the FDA make that decision.
We passed this unanimously from the good efforts of my colleague, the
Senator from Indiana, who will speak shortly, but also Senators
Alexander and Murray. We spent many hours in discussion crafting a bill
that passed unanimously.
By the way, that didn't surprise me because out of the 39 States that
passed Right to Try through their legislature, 38 have passed it and
signed it into law. Of the legislators who voted for Right to Try, 98
percent have voted yes. That is a vote tally of 5,604 to 126 because it
makes so much sense to give those terminally ill patients the freedom
to make those decisions themselves.
The good news is, the House passed the Right to Try bill--not
unanimously--with bipartisan support. The vote was 267 to 149, and 35
Democrats joined, most Republicans voting yes. A lot of that was due to
the good efforts from my Democratic colleague, the Senator from
Indiana.
I want to give a brief history on Right to Try in terms of my
involvement. I first went to the Goldwater Institute in 2014. They,
through their efforts, decided to go through the strategy of having
States pass it, and Colorado was the first State to pass Right to Try
in 2014.
Shortly after that meeting, I met a young mom, Trickett Wendler, a
mother of three children. She had ALS. I just mentioned the fact that I
had met with the Goldwater Institute, and I was fully in support of
Right to Try, and tears started streaming down the face of Trickett
Wendler. That is when I decided to become the champion and lead sponsor
of Right to Try in this body. Unfortunately, Trickett Wendler lost her
battle with ALS in March of 2015.
I want to briefly mention the other individuals for whom this bill is
named. Matt Bellina, a former lieutenant commander, Navy pilot, married
to
[[Page S1982]]
his wife Caitlyn Bellina, and he has three boys.
This is what Matt Bellina said in testimony:
Please let them know that I have had ALS too long to meet
the exclusion criteria for any promising trials. No drug
company will offer me treatments under the current expanded
access guidelines. Two reputable companies have already
indicated that they would try to treat me under the rules of
this bill. A vote against this is essentially a vote to kill
me. It is a vote to make my wife a widow and leave my boys
fatherless. I can't stop anyone from voting that way, but
please ask them to have respect to look my family in the eye
when they cast their vote.
Frank Mongiello is another victim of ALS. I just met with him a few
hours ago. I first met with him when he could speak--he can no longer
speak--but he spoke at our press conference, and here is his quote. He
paraphrased Abraham Lincoln and he said:
President Lincoln said, ``If I am killed, I die only once;
but if I dread it, I die over and over again.''
Frank went on to say:
I have an 80-percent chance to be dead in 2 years, and, for
me, seeing these potential drugs out on the market and not
being able to take them is like dying over and over again.
The final namesake of this bill is little Jordan McLinn. We met him
when he was 6 years old, and now he is 8. His mother Laura is a
tireless advocate. I know the Senator from Indiana knows the McLinns
well.
The FDA advisory committee on April 25 heard from, I think, 55
witnesses about a drug called eteplirsen to treat Duchenne's muscular
dystrophy. The advisory committee, having heard from people like Laura
and Jordan McLinn wanting access to that drug, voted no. Fortunately,
the FDA--and this is pretty rare--overruled the advisory committee, and
Jordan now is at least being treated. They are tireless advocates for
Right to Try.
These are the people we need to help. These are the people whom Right
to Try was meant for.
I don't know why it took the House 7 months to craft a bill and
finally vote on it. I can't tell you how many people during that 7
months sought treatment in other countries. I can't tell you if anyone
during that time period possibly lost their life because they didn't
have access to treatment. I don't know why the House felt compelled to
change the bill that we carefully crafted that passed unanimously. I
don't know why they simply didn't take up the Senate bill and pass it,
but I do know Right to Try saves lives.
I will quote one example, Dr. Delpassand, a courageous oncologist
from Houston. He was engaged in an FDA trial treating an aggressive
form of endocrine cancer. It was working. So he petitioned the FDA to
allow additional patients to be added to the trial. The FDA said no,
but Dr. Delpassand had a Right to Try bill in Texas. It didn't have
liability protection. He risked his career and all of his possessions
and he signed up additional people under the Texas Right to Try laws.
In the end, he signed up 176 people. We just checked with Dr.
Delpassand, and 148 of those individuals are still alive today because
of his courage. That is why we need to pass a Federal Right to Try law,
so individuals with that level of courage don't risk their careers, and
those patients have a chance to live.
I would like to yield to the Senator from Indiana for his remarks.
The PRESIDING OFFICER. The Senator from Indiana.
Mr. DONNELLY. Thank you, Mr. President, and thank you to the Senator
from Wisconsin.
I echo my support for this legislation. We worked together nonstop to
get this accomplished, as has been mentioned.
This passed the Senate 100 to nothing already. We are hopeful to wrap
this up. The House just sent us a vote back, and we will continue to
work nonstop to get this done because it is the right thing to do.
I think of the McLinn family in my home State, and they are a
representation of families all over the country struggling with the
same challenges. Our job is to try to make their lives a little bit
easier, a little bit better, so that all of the people who are
struggling with Right to Try challenges can get a chance to live their
life to the fullest and for a long time.
So, the hour is late. I just want to second the efforts of my friend
and colleague from Wisconsin, and we will continue to move forward.
The PRESIDING OFFICER. The Senator from Wisconsin.
Mr. JOHNSON. Mr. President, I thank the Senator from Indiana who has
been a real champion and a real partner. I know he tried to get as many
House Members to vote for the House bill as he could.
By the way, that was the good news. I am calling on the House now,
since we have an objection in the Senate on their bill, to please take
up the Senate bill. It is a nonpartisan bill that passed unanimously
through the Senate. Don't wait another hour. I know they are in recess
for a couple weeks, but I am calling on them, as soon as they come back
from recess, take up the Senate bill, pass it, and get it on the
President's desk. It is well past time to give these patients, these
terminally ill patients and their families, the Right to Try and the
right to hope. So I want to again thank the Senator from Indiana.
____________________